Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis - Contacts and Locations

Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis

This study has been terminated.

Study NCT00000430. Last updated on January 2, 2007. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000430

Locations


United States, Nebraska
	Creighton University Osteoporosis Research Center
	Omaha, Nebraska, United States, 68131

Sponsors and Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Investigators


Principal Investigator:	Robert R. Recker, MD	Creighton University Osteoporosis Research Center

Study Director:	Joan M. Lappe, PhD, RN	Creighton University Osteoporosis Research Center